Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of the latter at up to $1.25 billion. The consideration includes $925 million in upfront cash payment and an additional payment of up to $300m based […]
Boston Scientific acquisition of BTG : US medical devices manufacturer Boston Scientific has wrapped up its previously announced $4.2 billion acquisition of UK-based healthcare company BTG. In November 2018, Boston Scientific reached an agreement on the terms of a recommended offer to acquire the British healthcare company for a cash consideration of 840 pence per […]
Continue reading …US medical devices company Endologix, which develops minimally invasive treatments for aortic disorders, signed an agreement with medical devices manufacturer Boston Scientific under which the latter becomes the exclusive distributor for its products in China. The long-term agreement covers distribution rights to Endologix’s EndoVascular Aneurysm Repair (EVAR) and Endovascular Aneurysm Sealing (EVAS) products, and also […]
Continue reading …Boston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used for isolating pulmonary veins during treatment of patients with atrial fibrillation (AF), has achieved positive safety and efficacy results in the AF-FICIENT I clinical trial. Atrial fibrillation patients are usually treated with anti-arrhythmic drugs and […]
Continue reading …